2016
DOI: 10.1111/jcmm.12845
|View full text |Cite
|
Sign up to set email alerts
|

Insulin‐like growth factors and their potential role in cardiac epigenetics

Abstract: Cardiovascular disease (CVD) constitutes a major public health threat worldwide, accounting for 17.3 million deaths annually. Heart disease and stroke account for the majority of healthcare costs in the developed world. While much has been accomplished in understanding the pathophysiology, molecular biology and genetics underlying the diagnosis and treatment of CVD, we know less about the role of epigenetics and their molecular determinants. The impact of environmental changes and epigenetics in CVD is now eme… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 161 publications
(230 reference statements)
2
9
0
Order By: Relevance
“…IGF2 is another major paracrine growth signal released from epicardial cells and converges to the same downstream AKT and ERK signaling axis. 3,15 Conditional knockout of either IGF2 in the epicardium or its major receptor IGFR1 (IGF1 receptor) in cardiac progenitors (Nkx2-5+) resulted in reduced cardiomyocyte proliferation and ventricular wall hypoplasia. [16][17][18] In contrast, conditional deletion of IGF2 in the endocardium or myocardium did not give rise to any apparent cardiac phenotypes.…”
Section: What New Information Does This Articlementioning
confidence: 99%
See 1 more Smart Citation
“…IGF2 is another major paracrine growth signal released from epicardial cells and converges to the same downstream AKT and ERK signaling axis. 3,15 Conditional knockout of either IGF2 in the epicardium or its major receptor IGFR1 (IGF1 receptor) in cardiac progenitors (Nkx2-5+) resulted in reduced cardiomyocyte proliferation and ventricular wall hypoplasia. [16][17][18] In contrast, conditional deletion of IGF2 in the endocardium or myocardium did not give rise to any apparent cardiac phenotypes.…”
Section: What New Information Does This Articlementioning
confidence: 99%
“…3,19 Most previous research has focused on understanding the function or the downstream signaling of these growth factors. 12,15 How the expression of these growth factors in the developing epicardium is regulated is still poorly understood.…”
Section: What New Information Does This Articlementioning
confidence: 99%
“…Insulin-like growth factor (IGF) and IGF-II receptor (IGF-IIR) signaling is crucial for cardiac development and remodelling [13]. IGF-IIR is parentally imprinted and knocking down its expression had severe fetal cardiac abnormalities [4,5].…”
Section: Introductionmentioning
confidence: 99%
“…Either global deletion of FGF9 or conditional knockout of FGFR1/2 in the myocardium leads to ventricular hypoplasia 23 , suggesting that FGF9 and its downstream signaling is important for myocardial growth. IGF2 is another major paracrine growth signal released from epicardial cells and converges to the same downstream AKT and ERK signaling axis 5, 29 . Conditional knockout of either IGF2 in the epicardium or its major receptor, IGFR1 in cardiac progenitors (Nkx2-5+) resulted in reduced cardiomyocyte proliferation and ventricular wall hypoplasia 24-26 .…”
Section: Introductionmentioning
confidence: 99%
“…In the developing heart, FGF9 and IGF2 are mainly secreted by the epicardium and its EPDCs, with minor contributions from cardiac endothelial cells 5, 20 . Most previous research has focused on understanding the function and/or the downstream signaling of these growth factors 27, 29 . How the expression of these growth factors in the developing epicardium is regulated is still poorly understood.…”
Section: Introductionmentioning
confidence: 99%